• Title/Summary/Keyword: Trial Division

Search Result 620, Processing Time 0.029 seconds

Current progress on development of respiratory syncytial virus vaccine

  • Chang, Jun
    • BMB Reports
    • /
    • v.44 no.4
    • /
    • pp.232-237
    • /
    • 2011
  • Human respiratory syncytial virus (HRSV) is a major cause of upper and lower respiratory tract illness in infants and young children worldwide. Despite its importance as a respiratory pathogen, there is currently no licensed vaccine for prophylaxis of HRSV infection. There are several hurdles complicating the development of a RSV vaccine: 1) incomplete immunity to natural RSV infection leading to frequent re-infection, 2) immature immune system and maternal antibodies of newborn infants who are the primary subject population, and 3) imbalanced Th2-biased immune responses to certain vaccine candidates leading to exacerbated pulmonary disease. After the failure of an initial trial featuring formalin-inactivated virus as a RSV vaccine, more careful and deliberate efforts have been made towards the development of safe and effective RSV vaccines without vaccine-enhanced disease. A wide array of RSV vaccine strategies is being developed, including live-attenuated viruses, protein subunit-based, and vector-based candidates. Though licensed vaccines remain to be developed, our great efforts will lead us to reach the goal of attaining safe and effective RSV vaccines in the near future.

Novel Tools and Techniques of Today and Tomorrow: For Studying Catalysis and Energy Problems

  • Hussain, Zahid
    • Proceedings of the Korean Vacuum Society Conference
    • /
    • 2013.02a
    • /
    • pp.127-127
    • /
    • 2013
  • The quest for renewable energy requires us to understand, predict, and ultimately control matter and energy at the electronic, atomic, and molecular levels. The ever-increasing demand to diversify the energy portfolio and to minimize environmental impact while supplying global energy needs, has intensified the urgency for developing alternative energy sources and carriers. Significant research efforts are under way and will continue in a broad range of materials synthesis, use-inspired and fundamental science with the use of light sources such as synchrotron and free electron lasers. Energy-related materials research faces urgent challenges today. We need to go beyond the Edisonian hit and trial approach to more systematic research with the use of advanced tools applicable under realistic in-situ and in-operando conditions capable of exploring electronic and atomic structure of catalysts and energy relevant materials. Through various scientific examples, I will explain the current state-of-the art and future directions in the aforementioned areas of research.

  • PDF

Adaptive Scanning Method for Fine Granularity Scalable Video Coding

  • Park, Gwang-Hoon;Kim, Kyu-Heon
    • ETRI Journal
    • /
    • v.26 no.4
    • /
    • pp.332-343
    • /
    • 2004
  • One of the recent and most significant technical properties can be expressed as "digital convergence," which is helping lead the technical paradigm into a ubiquitous environment. As an initial trial of realizing a ubiquitous environment, the convergence between broadcasting and telecommunication fields is now on the way, where it is required to develop a scalable video coding scheme for one-source and multi-use media. Traditional scalable video coding schemes have, however, limitations for higher stable picture quality especially on the region of interest. Therefore, this paper introduces an adaptive scanning method especially designed for a higher regional-stable picture quality under a ubiquitous video coding environment, which can improve the subjective quality of the decoded video by most-preferentially encoding, transmitting, and decoding the top-priority image information of the region of interest. Thus, the video can be more clearly visible to users. From various simulation results, the proposed scanning method in this paper can achieve an improved subjective picture quality far better than the widely used raster scan order in conventional video coding schemes, especially on the region of interest, and without a significant loss of quality in the left-over region.

  • PDF

Clinical Application of $^{18}F-FDG$ PET in Alzheimer's Disease (알쯔하이머병(Alzheimer's disease)에서 FDG PET의 임상이용)

  • Ryu, Young-Hoon
    • Nuclear Medicine and Molecular Imaging
    • /
    • v.42 no.sup1
    • /
    • pp.166-171
    • /
    • 2008
  • PET of the cerebral metabolic rate of glucose is increasingly used to support the clinical diagnosis in the examination of patients with suspected major neurodegenerative disorders, such as Alzheimer's disease. $^{18}F-FDG$ PET has been reported to have high diagnostic performance, especially, very high sensitivity in the diagnosis and clinical assessment of therapeutic efficacy. According to clinical research data hitherto, $^{18}F-FDG$ PET is expected to be an effective diagnostic tool in early and differential diagnosis of Alzheimer's disease. Since 2004, Medicare covers $^{18}F-FDG$ PET scans for the differential diagnosis of fronto-temporal dementia (FTD) and Alzheimer's disease (AD) under specific requirements; or, its use in a CMS approved practical clinical trial focused on the utility of $^{18}F-FDG$ PET in the diagnosis or treatment of dementing neurodegenerative diseases.

c-Jun N-Terminal Kinase Signaling Inhibitors Under Development

  • Han, Sun-Young
    • Toxicological Research
    • /
    • v.24 no.2
    • /
    • pp.93-100
    • /
    • 2008
  • Targeting protein kinases has been active area in drug discovery. The c-Jun N-terminal kinases(JNKs) have also been target for development of novel therapy in various diseases, since the roles of JNK signaling in pathological conditions were revealed in studies using jnk-deficient mice. Small molecule inhibitors and peptide inhibitors are identified for therapeutic intervention of JNK signaling pathway. SP-600125, an anthrapyrazole small molecule inhibitor for JNK with high potency and selectivity has been widely used for dissecting JNK signaling pathway. CC-401 is the first JNK inhibitor that went into clinical trial for inflammation and leukemia. Inhibitor for mixed lineage kinase (MLK), CEP-1347 also negatively regulates JNK signaling, and tried for potential use in Parkinson's disease. Cell-permeable peptide inhibitor D-JNKI-1 is being developed for the treatment of hearing loss. The current status of these JNK inhibitors and safety issue is discussed in the minireview.

Improvement of trajectory tracking control performance by using ILC

  • Le, Dang-Khanh;Nam, Taek-Kun
    • Journal of Advanced Marine Engineering and Technology
    • /
    • v.38 no.10
    • /
    • pp.1281-1286
    • /
    • 2014
  • This paper presents an iterative learning control (ILC) approach for tracking problems with specified data points that are desired points at certain time instants. To design ILC systems for such problems, unlike traditional ILC approaches, an algorithm which updates not only the control signal but also the reference trajectory at each trial will be developed. The relationship between the reference trajectory and ILC control in tracking problems where there are specified data points through which the system should pass is investigated as the rate of convergence. In traditional ILC, the desired data is stored in a tracking profile file. Due to the huge size of the data file containing the target points, it is important to reduce the computational cost. Finally, simulation results of the presented technique are mentioned and compared to other related works to confirm the effectiveness of proposed scheme.

Factors Related to Dropout in Clinical Trials of Acupuncture and Moxibustion (침구 임상시험에서의 중도탈락 관련요인)

  • Kim, Ae-Ran;Lee, Moo-Sik;Hong, Jee-Young
    • The Journal of Korean Medicine
    • /
    • v.32 no.4
    • /
    • pp.128-138
    • /
    • 2011
  • Objective: This study aimed at providing preliminary data useful in reducing participant dropout and improving the quality of clinical trials, by analyzing the factors related to dropout. Methods: The data came from 15 acupuncture and/or moxibustion clinical trials (n=638; August 2005 to December 2009). Logistic regression analysis was used to reveal factors influencing participant dropout. Results: Gender, age, treatment method (intervention), treatment frequency, availability of follow-up, and presence of compensation treatment for the control group were factors influencing participant dropout. Conclusion: Subsequent studies of large-scale acupuncture and moxibustion clinical trials should address dropout factors that consider the character of each clinical trial, or general characters like participants' gender, age, occupation, and diverse diseases.

Forming Analysis and Design of Cold Gear Forging using 3D Finite Element Method (3차원 유한요소법을 적용한 냉간단조 기어 성형 해석 및 설계)

  • 송종호;김수영;임용택
    • Proceedings of the Korean Society for Technology of Plasticity Conference
    • /
    • 2002.05a
    • /
    • pp.108-111
    • /
    • 2002
  • It is important to predict forming procedure for minimizing trial-and-error in the application of cold forging of gears. In this study, 3-dimensional simulations of cold forging processes of spur and bevel gear were carried out using finite element method to investigate the characteristics of the processes. From the simulation result it was found that incomplete teeth forming of spur gear was occurred with increase of teeth number in forging by forward extrusion. It can be reduced through division of material flows at the initial forming state using forward/backward combined extrusion.

  • PDF

Success and Failure Factors of Technology Commercialization: A Korean Case

  • Kim, Chan-Ho;Ko, Chang-Ryong
    • Asian Journal of Innovation and Policy
    • /
    • v.3 no.1
    • /
    • pp.25-49
    • /
    • 2014
  • We wanted to show the different group dynamics of factors for success and failure cases for technology commercialization in small technology-based firms. Existing studies are based on product level, project level, division level or firm level. We deal with technology level, and at small-technology-based firms. This is a longitudinal case study based on 8 cases from Korea. Our study on technology level is a first trial in success and failure studies unlike all existing studies. As a first step, we introduced new categories and factors such as technology attributes and CEO reflecting data, and especially a new concept of launch readiness level. Finally, we adopted correspondence analysis to show the group dynamics. The results are as follows; Technology factors are the most important factors. Second, resource-based factors are more critical in failure cases than success cases and technology factors are more critical to success.

Two Bayesian methods for sample size determination in clinical trials

  • Kwak, Sang-Gyu;Kim, Dal-Ho;Shin, Im-Hee;Kim, Ho-Gak;Kim, Sang-Gyung
    • Journal of the Korean Data and Information Science Society
    • /
    • v.21 no.6
    • /
    • pp.1343-1351
    • /
    • 2010
  • Sample size determination is very important part in clinical trials because it influences the time and the cost of the experimental studies. In this article, we consider the Bayesian methods for sample size determination based on hypothesis testing. Specifically we compare the usual Bayesian method using Bayes factor with the decision theoretic method using Bayesian reference criterion in mean difference problem for the normal case with known variances. We illustrate two procedures numerically as well as graphically.